Randomized, open-label, tolterodine-controlled, comparative study of the novel antimuscarinic agent imidafenacin in patients with overactive bladder
Neurourology and Urodynamics | Mar 22, 2019
Microrna dysregulation and non-muscle-invasive bladder cancer prognosis
Cancer Epidemiology, Biomarkers & Prevention | Mar 20, 2019
CD163+ macrophages predict a poor prognosis in patients with primary T1 high-grade urothelial carcinoma of the bladder
World Journal of Urology | Mar 19, 2019
Effect of chemotherapy with docetaxel with androgen suppression and radiotherapy for localized high-risk prostate cancer: The randomized phase III NRG Oncology RTOG 0521 trial
Journal of Clinical Oncology | Mar 18, 2019
Most read this week